Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Metabolic Enzyme/Protease

Items 1-10 of 39

Page
per page
  1. INCB-024360 Epacadostat
    B6036 INCB-024360 Epacadostat
    Target: IDO
    Summary: Orally active indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor
      insoluble in H2O; ≥17.1 mg/mL
  2. Valproic acid sodium salt
    A4099 Valproic acid sodium salt
    Target: Histone Deacetylases (HDACs)
    Summary: A class I HDAC inhibitor
      ≥8.35 mg/mL
  3. Telaglenastat
    B4799 Telaglenastat
     1 Citation
    Target: Glutaminases
    Summary: Orally active glutaminase inhibitor
      ≥28.6 mg/mL
  4. Dibutyryl-cAMP, sodium salt
    B9001 Dibutyryl-cAMP, sodium salt
    Summary: cell-permeable cAMP analog
      ≥49.1 mg/mL
  5. Berberrubine
    N2089 Berberrubine
    Summary: An isoquinoline alkaloid with diverse biological activities. It could be used for ulcerative colitis models
      insoluble in H2O; insoluble in EtOH; ≥6.42 mg/mL
  6. NNK
    BA7418 NNK
    Summary: Nicotine-derived nitrosamine; NNK for lung cancer mouse models
      ≥32.1 mg/mL
  7. Lithocholic Acid
    A8463 Lithocholic Acid
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: Toxic secondary bile acid; induces intrahepatic cholestasis; FXR antagonist and PXR/SXR agonist
      insoluble in H2O; ≥12.95 mg/mL
  8. Tamoxifen
    B5965 Tamoxifen
     1 Citation
    Target: PKC
    Summary: estrogen receptor modulator
      ≥18.6 mg/mL
  9. 4-Aminobenzamidine dihydrochloride
    A9911 4-Aminobenzamidine dihydrochloride
    Summary: A protease inhibitor
      ≥24.75 mg/mL
  10. 2-Hydroxypalmitic acid
    A9919 2-Hydroxypalmitic acid
    Summary: A kind of hydroxyl fatty acid
      ≥25.1 mg/mL

Items 1-10 of 39

Page
per page